充血性心力衰竭患者血清细胞因子的变化及辛伐他汀的干预作用

目的：探讨充血性心力衰竭（CHF）患者血清TNF－α和IL－6的变化及辛伐他汀对其水平的影响。方法：采用双抗体夹心ELISA法测定44例CHF患者和30例健康对照者血清TNF－α和IL－6浓度，将CHF患者随机分为辛伐他汀组和常规治疗组治疗，15d后重复测定上述指标。结果：CHF组患者血清TNF－α和IL－1水平明显高于对照组（P＜0．01），且与心功能损害程度密切相关；CHF组患者经15d治疗后血清TNF－α和IL－6水平均明显下降（P＜0．05），但辛伐他汀组较常规治疗组血清TNF－α和IL－6 更为明显（P＜0．05），结论：CHF患者血清TNT－α和IL－6水平明显增高且与心功能状态密切相关，在常规治疗的基础上加用辛伐他汀能进一步降低TNF－α和IL-6的水平，提示辛伐他汀可能具有减缓心脏损伤的进程、保护和改善CHF患者心功能的作用。     

重型肝炎并发自发性细菌性腹膜炎患者血清及腹水中NO、TNF—α、IL—6、IL—12水平变化及意义

为探讨一氧化氮（NO）、肿瘤坏死因子－α（TNF-α）、白细胞介素－6（IL－6）、白细胞介素－12（IL－12）在重型肝炎（SH）并发自发性细菌性腹膜炎（SBP）患者血清和腹水中的水平及其临床意义,分别采用Griess比色法及放射免疫法（RIA）检测了45例SH并发腹水患者血清及腹水中NO、TNF－α、IL－6和IL－12含量,其中腹水感染30例,腹水非感染组15例,结果显示SH并发SBP血清和腹水NO、TNF－α、IL－6和IL－12水平均明显高于腹水非感染组（P＜0．05）,其升高水平与血清总胆红素（SB）、凝血酶原时间（PT）呈正相关,与血清胆固醇呈负相关（P＜0．01）,感染控制后血清和腹水NO、TNF－α、IL－6、IL－12水平均明显下降（P＜0．05）,但汉能降至非感染组水平。表明：NO、TNF－α、IL－6和IL－12参与SH及SBP形成腹水的发生、发展过程,其联合检测对SH并发SBP的早期诊断、病情轻重及强后的判断有一定指导意义。     

肝硬化患者血浆和腹水中一氧化氮、白细胞介素—6和肿抗坏死因子α的研究

目的：研究肝硬化患者血浆和腹水一氧化氮（NO）、白细胞介素－6（IL－6）及肿瘤坏死因子α（TNFα）的变化及其意义。方法：用比色法、ELISA法分别测定50例肝硬化患者血浆和腹水的NO、IL－6及TNFα。结果：肝硬化组血浆和腹水NO、IL－6及TNFα水平均显著高于对照组（P＜0．01）。腹水渗出液中NO、IL－6及TNFα水平明显高于漏出液（P＜0．01或0．05）。结论：检测血浆和腹水中NO、IL－6及TNFα有助于肝硬化腹水的鉴别诊断。     

急性白血病患者血清IL-6、TNF-α检测临床意义的探讨

目的：探讨白细胞介素6（IL－6）肿瘤坏死因子α（TNF－α）水平与急性白血病（AL）发病的关系。方法：采用ELISA双抗体夹心法测定急性淋巴细胞白血病（ALL）和急性髓细胞白血病（AML）患血清IL－6、TNF－α水平。结果：AL患IL－6含量显高于正常对照组（P＜0．01），且ALL又明显高于AML（P＜0．05）；TNF－α也显高于对照组（P＜0．01），但ALL与AML两组间TNF－α水平无明显差异（P＞0．05）。结论：IL－6、TNF－α水平与AL发病，发展有密切相关；IL－6水平与白血病类型有关；而TNF－α水平与白血病类型无关。     

急性胰腺炎急性期血清TNF-α、IL-6和IL-10变化的实验研究

目的 研究急性胰腺炎急性期血清TNF－α、IL－6和IL－10的变化。方法 分别以1％和5％牛磺胆酸钠（0．1ml/100g)胰胆管注射建立急性水肿性胰腺炎（AEP）和急性坏死性胰腺炎（ANP）模型。雄性SD大鼠48只随机平均分为Sham(假手术）组，AEP组，ANP组3组。分别于造模后3h,6h处死8只动物，分别观察血清TNF－α、IL－6和IL－10的变化。结果 ANP组和AEP组血清TNF－α、IL－6和IL－10显著升高（均P＜0．001）。造模后6h的血清TNF－α，3h和6h的血清IL－6，IL－10在ANP组均较AEP组为高（分别P＜0．05，P＜0．001，P＜0．05）。ANP组血清TNF－α、IL－6水平在造模后6h比3h为高（均P＜0．05）。结论 在急性胰腺炎病程中细胞因子（TNF－α、IL－6，IL－10）起了重要的作用。IL－6有助于早期判断胰腺坏死。     

精神分裂症患者血清细胞因子的检测及意义

目的：探讨细胞因子在精神分裂症发病中的作用。方法：采用酶联免疫吸附法(ELISA）分别40例精神分裂症患者和30例对照者的血清白细胞介素2（IL－2）、白细胞介素6（IL－6）、白细胞介素1β（IL-1β）和肿瘤坏死因子α（TNFα）水平。结果：精神分裂症患者血清IL－2和IL－6水平均显著高于健康对照者（P均＜0．01），且患病期其水平明显高于恢复期（P＜0．05和P＜0．01），另外，精神分裂症患者IL－2和IL－6瓣高低与其性别、病程、病情的严重程度及家族史有关（P均＜0．01），但患者血清IL－1β和TNFα水平与对照组差异无显著性（P均＞0．05），结论：精神分裂症患者存在免疫功能紊乱，其患病期细胞因子水平可能与疾病的严重程度及遗传因素有关。     

TNF-α和IL-10基因多态性预测肾移植效果的临床研究

目的：探讨TNF－α和IL－10基因多态性预测移植肾急性排斥反应的临床意义，方法：用序列特异引物聚合酶链反应（PCR－SSP）方法，对126例肾移植患者进行TNF－α和IL－10基因型检测。结果：肾移植后急性排斥反应发生率，TNF－α为高分泌基因型的患者显著高于低分泌基因型者（P＜0．01），IL－10为高分泌基因型的患者显著高于低分泌基因型者（P＜0．05），TNF－α与IL－10均为高分泌基因型的患者比所有其他基因型组合者高（P＜0．01），TNF－α与IL－10均为低分泌基因型患者比所有其他基因型组合者低（P＜0．05），结论：常规检测TNF－α和IL－10基因多态性对于预测移植效果具有重要意义。     

肝硬变患者血清IL—6，TNF—α检测的临床意义

目的：探讨肝硬变患者血清中IL－6,TNF－α检测的临床意义。方法：应用ELISA双抗体夹心法测定血清IL－6,TNF－α。结果：肝硬变组IL－6,TNF－α显著高于对照组（P＜0．001）,且与肝硬变Child-Pugh分级严重程度相一致。肝硬变合并腹腔感染者IL－6,TNF－α较非感染者显著升高（P＜0．001）。结论：IL－6,TNF－α水平的测定,可作为判断肝硬变肝功能严重程度及是否合并腹腔感染的临床指标之一。     

脑出血患者相关炎症因子变化与预后的相关性研究

目的：探讨脑出血患者相关炎症因子变化与预后的相关性。方法：选取急性脑出血患者80例为脑出血组、同期门诊中老年体检者80例为对照组,脑出血组入院后进行急性生理和慢性健康状况评分（ APACHE－II）评估,观察预后,脑出血组在入院后、对照组在体检时抽取外周空腹静脉血检测血清白细胞介素－10（IL－10）、白细胞介素－6（IL－6）、白细胞介素－1（IL－1）、敏感C反应蛋白（hs－CRP ）、肿瘤坏死因子－α（ TNF－α）水平。结果：脑出血组患者血清IL－10、IL－6、IL－1、hs－CRP、TNF－α水平均明显高于对照组（P＜0．05）;APACHE－II 评分5－16分者42例（轻型）,17－28分者26例（中型）,29分以上者12例（重型）,不同APACHE－II评分时患者IL－10、IL－6、IL－1、hs－CRP、TNF－α水平比较明显不同（ P＜0．05）,中型、重型者均高于轻型（ P＜0．05）,重型高于中型（ P＜0．05）;14例患者死亡,66例患者存活,死亡患者IL－10、IL－6、IL－1、hs－CRP、TNF－α水平明显高于存活患者（ P＜0．05）。结论：脑出血患者血清炎症因子IL－10、IL－6、IL－1、hs－CRP、TNF－α等均升高,病情越重、预后不佳的患者升高更为明显,IL－10、IL－6、IL－1、hs－CRP、TNF－α水平与患者病情严重程度及预后关系密切。     

胎儿宫内发育迟缓孕妇血清及羊水中白细胞介素—1β及肿瘤坏死因子—α水平的研究

目的：探讨孕妇血清及羊水中白细胞介素1β（IL－1β）及肿瘤坏死因子－α（TNF－α）与胎儿宫内发育迟缓（IUGR）的关系。方法：采用酶联免疫吸附法（ELISA）检测正常足月孕妇及IUGR孕妇血清及羊水中IL－1β及TNF－α水平，并进行比较分析。结果：IUGR组与正常分娩组孕妇血清中IL－1β、TNF1－α水平比较，无统计学意义（P＞0．05）；而IUGR组羊水中IL－1β明显低于对照组，TNF－α则明显高于对照组，均存在显性差异（P＜0．01）；在预测IUGR方面，羊水中TNF－α水平变化较IL1β更有价值。结论：羊水中IL－1β及TNF－α水平变化与IUGR的发生密切相关。     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Acupuncture Treatment of Vomiting

CASE HISTORY A female patient, 46 years old, head of the foreign affairs department of a certain university in Beijing, paid her first visit on October 9, 2006, with the chief complaint of vomiting for one month. She got vomiting after meals in early September. Before that, she had discomfortable sensation in the stomach due to angry with others, but she didn't pay much attention. Later, it developed into vomiting after eating. After the vomiting, the discomfort would be relieved, but with slight hypodynamia. She was once diagnosed as having 'neurogenic vomiting'. Having taken some western and Chinese drugs, the above symptoms were a little bit improved, but she would have nausea upon eating and with regurgitation. Because of the fear for vomiting, she did not dare to have food intake, with body weight reduction of 6 kilos in one month.     

Qiu Baoguo''''s Experience in Treating Consumptive Syndromes after Radio-Chemotherapies

Radiotherapy and chemotherapy are the important modern medical therapies for malignant tumors,yet they can also bring about serious local and systemic toxic side reactions so to decrease the patient;'s life quality,manifested by a series of consumptive symptoms.Having engaged in the combined work of Chinese and western medicine for nearly 50 years,the research fellow Qiu Baoguo in Henan Provincial Academy of TCM has developed his unique views on the TCM study of consumptive syndromes.The author of this essay had once the fortune tO follow Dr.Qiu in clinic,and specially would like to introduce in the following Dr.Qiu's experience in treating consumptive syndromes after radio-chemotherapies for patients with malignant tumor.     

Insomnia Due to Deficiency of Both the Heart and Spleen Treated by Acupuncture-Moxibustion and Chinese Tuina

OBJECTIVE: To observe therapeutic effects of the comprehensive therapy of acupuncture-moxibustion and Chinese Tuina for treatment of insomnia due to deficiency of both the heart and spleen. METHODS: 92 cases were divided randomly into the treatment group (treated by acupuncture-moxibustion and Chinese Tuina) and the control group (treated by acupuncture-moxibustion). RESULTS: The therapeutic effect of the treatment group was obviously superior to that of the control group (the CHI2 test showed P < 0.01). CONCLUSIONS: The comprehensive therapy of acupuncture-moxibustion and Chinese Tuina can give marked therapeutic effects for treatment of insomnia due to deficiency of both the heart and spleen.     

Analysis of CK-19,PDX-1,Nestin,Ngn3 in different donor islet purity in rats

Objective: To investigate if there are the CK-19, PDX-1, Nestin, Ngn3 positive cells in the donor islets of different purity in rats. Methods: Thirty male adult SD rats were randomly divided into 3 groups. Islets were isolated using digestion by ductal injection of collagenase. Group Ⅰ (n=10): Separating cell preparations were not purified, Group Ⅱ(n=10): Islet sediment was purified with 25% Ficoll400 ,Group Ⅲ (n=10): Islet sediment was purified with 25% and 11% Ficoll-400. The levels of protein of CK-19, PDX-1, Nestin and Ngn3 were detected by immunohistochemistry and the mRNA of CK-19, PDX-1, Nestin, Ngn3 was amplified by RT-PCR. Results: After two different purification methods applied, three islet preparations of different purities were obtained. The difference of islet purity was significant among various groups (P＜0.05). Compared with group Ⅱ and group Ⅲ,the protein and mRNA of CK-19, PDX-1, Nestin,Ngn3 were both higher in group Ⅰ; group Ⅲ was poorly expressed. Conclusions: The three different islet purity donor islet have different CK-19, PDX-1, Nestin, Ngn3 positive cells within them, indicating that there are some islet stem cells in the purified donor islet.     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.